Deep learning and virtual drug screening.

Carpenter, Kristy A; Cohen, David S; Jarrell, Juliet T; Huang, Xudong

Carpenter, Kristy A; Cohen, David S; Jarrell, Juliet T; Huang, Xudong.

Afiliación

Carpenter KA; Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA 02129, USA.
Cohen DS; Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA 02129, USA.
Jarrell JT; Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA 02129, USA.
Huang X; Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Charlestown, MA 02129, USA.

Future Med Chem ; 10(21): 2557-2567, 2018 11.

Article en En | MEDLINE | ID: mdl-30288997

Asunto(s)

Aprendizaje Profundo; Descubrimiento de Drogas/métodos; Humanos; Ligandos; Redes Neurales de la Computación

Palabras clave

artificial intelligence; artificial neural networks; convolutional neural networks; deep learning; drug discovery; machine learning; multitask learning; virtual screening

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Descubrimiento de Drogas / Aprendizaje Profundo Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Future Med Chem Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google